Fuller & Thaler Asset Management
PDLI

Fuller & Thaler Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Fuller & Thaler Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,129,470
Closed -$3.56M – 550
2020
Q3 		$3.56M Sell
1,129,470
-56,630
-5% -$181K 0.05% 247
2020
Q2 		$3.45M Sell
1,186,100
-30,590
-3% -$96.7K 0.05% 246
2020
Q1 		$3.43M Buy
1,216,690
+107,545
+10% +$347K 0.06% 219
2019
Q4 		$3.6M Buy
1,109,145
+3,175
+0.3% +$9.22K 0.04% 241
2019
Q3 		$2.39M Sell
1,105,970
-137,155
-11% -$367K 0.03% 264
2019
Q2 		$3.9M Sell
1,243,125
-6,915
-0.6% -$22.4K 0.05% 222
2019
Q1 		$4.65M Buy
1,250,040
+18,310
+1% +$61.8K 0.06% 197
2018
Q4 		$3.57M Buy
1,231,730
+20,580
+2% +$56.5K 0.05% 206
2018
Q3 		$3.19M Hold
1,211,150
– – 0.03% 259
2018
Q2 		$2.83M Sell
1,211,150
-150
-0% -$419 0.03% 268
2018
Q1 		$3.56M Sell
1,211,300
-86,000
-7% -$235K 0.04% 233
2017
Q4 		$3.56M Sell
1,297,300
-404,200
-24% -$1.24M 0.04% 207
2017
Q3 		$5.77M Sell
1,701,500
-8,000
-0.5% -$22.2K 0.07% 156
2017
Q2 		$4.22M Buy
1,709,500
+1,004,700
+143% +$2.31M 0.06% 167
2017
Q1 		$1.6M Buy
+704,800
New +$1.56M 0.02% 237

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Fuller & Thaler Asset Management's PDLI Position: Q4 2020 in Review

Fuller & Thaler Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 1,129,470 shares — an estimated $3.56M sold.

Fuller & Thaler Asset Management first reported a position in PDLI in Q1 2017 and held it in 15 quarters. The position peaked at $5.77M in Q3 2017. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Fuller & Thaler Asset Management reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 1,129,470 PDL BioPharma, Inc. shares in Q4 2020, an estimated $3.56M.
  • Fuller & Thaler Asset Management first reported a position in PDL BioPharma, Inc. in Q1 2017 and held it in 15 quarters.
  • Fuller & Thaler Asset Management's PDL BioPharma, Inc. position peaked at $5.77M in Q3 2017.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.